Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1996
06/27/1996WO1996019459A1 Novel sulfonamides
06/27/1996WO1996019458A2 Steroid receptor modulator compounds and methods
06/27/1996WO1996019455A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
06/27/1996WO1996019451A1 Substituted azetidin-2-ones for treatment of atherosclerosis
06/27/1996WO1996019450A1 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
06/27/1996WO1996019440A1 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase
06/27/1996WO1996019437A1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
06/27/1996WO1996019428A1 Biocidal alcohols, their production and their use
06/27/1996WO1996019243A1 Composition for treatment of malignant tumors and their metastases
06/27/1996WO1996019233A2 Irrigation solution and method for inhibition of pain, inflammation and spasm
06/27/1996WO1996019232A1 Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
06/27/1996WO1996019230A1 Soluble 2-chloro-2'-deoxyadenosine formulations
06/27/1996WO1996019229A1 Stable solutions of 2-chloro-2'-deoxyadenosine formulations
06/27/1996WO1996019228A1 Formulations and methods for reducing skin irritation
06/27/1996WO1996019227A1 Cyclophasic hormonal regimen containing antiprogestin and progestin
06/27/1996WO1996019226A1 Combination chemotherapy of suramin and a vinca-alkaloid or estramustine
06/27/1996WO1996019225A1 Method for protecting the heart from ischemia
06/27/1996WO1996019224A1 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof
06/27/1996WO1996019223A1 Fibrinogen receptor antagonists
06/27/1996WO1996019222A1 Fibrinogen receptor antagonists
06/27/1996WO1996019220A1 A combination product comprising nitazoxanide and an anti-ulcer agent
06/27/1996WO1996019219A1 Method for treating opiate withdrawal
06/27/1996WO1996019218A1 Tocopherol and tocotrienol compositions
06/27/1996WO1996019217A1 Pharmaceutical compositions comprising lycopene
06/27/1996WO1996019216A1 Compositions based on tocopherols
06/27/1996WO1996019215A1 Compositions of tocopherol and beta-carotene
06/27/1996WO1996019214A1 Method and compositions for topical application of tocotrienol to the skin
06/27/1996WO1996019213A1 Novel anti-proliferative effects of sodium butyrate
06/27/1996WO1996019212A1 Use of boswellic acid for treating brain tumours
06/27/1996WO1996019211A1 Liposome eye drops
06/27/1996WO1996019210A1 Remedy for ischemic diseases
06/27/1996WO1996019209A1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours
06/27/1996WO1996019208A1 Use of a vitamin of the k group for treating hyperparathyroidism
06/27/1996WO1996019204A1 Medicated tissue paper product
06/27/1996WO1996019203A1 Transdermal system for the simultaneous delivery of a number of active principles
06/27/1996WO1996019202A1 Ibuprofen enhancing solvent system
06/27/1996WO1996019199A1 Proliposome powders for inhalation
06/27/1996WO1996019196A1 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
06/27/1996WO1996019186A1 Antifungal treatment of nails
06/27/1996WO1996019184A1 Formulations and methods for reducing skin irritation
06/27/1996WO1996019183A1 Formulations and methods for reducing skin irritation
06/27/1996WO1996019119A1 Silicone compositions
06/27/1996WO1996015786A3 Oral compositions containing ondansetron
06/27/1996WO1996011680A3 Use of gaba agonists in the treatment of emesis
06/27/1996DE4447374A1 New siderophore cpds. esp. myxochelin C, used as chelating agents
06/27/1996DE4447361A1 Biozide Alkohole, ihre Herstellung und ihre Verwendung Biocides alcohols, their preparation and their use
06/27/1996DE4446600A1 Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen Transdermal absorption of drugs from undercooled melts
06/27/1996DE4446025A1 2-Caroxamido-1,4,5,6-tetrahydropyrazine 2-Caroxamido-1,4,5,6-tetrahydropyrazine
06/27/1996DE4446024A1 Verwendung eines Vitamins der K-Gruppe Use of a vitamin K-Group
06/27/1996DE4445968A1 Use of new and known sulphonyl guanazine cpds.
06/27/1996DE4445891A1 Rekombinante Proteinase aus Clostridium histolyticum und ihre Verwendung zur Isolierung von Zellen und Zellverbänden Recombinant proteinase from Clostridium histolyticum and their use for the isolation of cells and cell aggregates
06/27/1996DE4445728A1 Verwendung von Boswelliasäure zur Behandlung von Hirntumoren Use of boswellic acid for the treatment of brain tumors
06/27/1996DE19547958A1 Anthracyclin-Derivate Anthracycline derivatives
06/27/1996CA2341921A1 Amide compounds intermediates
06/27/1996CA2208773A1 Heterocyclic keto arginine peptides as thrombin inhibitors
06/27/1996CA2208772A1 Low molecular weight bicyclic thrombin inhibitors
06/27/1996CA2208530A1 Substituted azetidin-2-ones for treatment of atherosclerosis
06/27/1996CA2208518A1 Substituted thiadiazoles, compositions containing them and their use as antimicrobial and marine antifouling agents
06/27/1996CA2208517A1 Proliposome powders for inhalation
06/27/1996CA2208508A1 Therapeutic agent for ischemic diseases
06/27/1996CA2208485A1 Method for protecting the heart from ischemia
06/27/1996CA2208458A1 Thienoxazinone derivatives useful as antiviral agents
06/27/1996CA2208374A1 Transdermal system for the simultaneous delivery of a number of active principles
06/27/1996CA2208347A1 Steroid receptor modulator compounds and methods
06/27/1996CA2208324A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups
06/27/1996CA2208316A1 Oxazole derivatives and use thereof
06/27/1996CA2208268A1 Formulations and methods for reducing skin irritation
06/27/1996CA2208244A1 Tetracyclic spiro compounds, process for their preparation and their use as 5ht1d receptor antagonists
06/27/1996CA2208240A1 Novel quinoxalines and drugs prepared therefrom
06/27/1996CA2208088A1 Antifungal treatment of nails
06/27/1996CA2208011A1 Aryl-and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
06/27/1996CA2208007A1 Cyclophasic hormonal regimen containing antiprogestin and progestin
06/27/1996CA2206978A1 Diaryl-2-(5h)-furanones as cox-2 inhibitors
06/27/1996CA2206112A1 Combination chemotherapy of suramin and a vinca-alkaloid or estramustine
06/27/1996CA2206046A1 Quinazolines as inhibitors of endothelin converting enzyme
06/27/1996CA2205863A1 Liposome eye drops
06/27/1996CA2192854A1 Novel anti-proliferative effects of sodium butyrate
06/27/1996CA2183645A1 Heterocyclic aromatic oxazole compounds and use thereof
06/27/1996CA2166017A1 Pharmaceutical composition for the dermatitis
06/27/1996CA2165999A1 Pharmaceutical composition for topical administration to eye for treating allergic conjunctivitis
06/27/1996CA2165919A1 Agents for inhibiting the production of il-1.beta. and the release of tnf.
06/27/1996CA2165895A1 Platinum complex and malignant tumor treating drug containing the same
06/26/1996EP0718400A2 Methods and compositions for controlling translation of HCV proteins
06/26/1996EP0718312A2 Crosslinked acidic polysaccharides and their uses
06/26/1996EP0718307A2 Derivatives of 1-oxo-2-(phenylsulfonyl-amino)-pentylpiperidine, their preparation and therapeutic use
06/26/1996EP0718299A1 Tricyclic oxime ethers process for their preparation and pharmaceutical compositions containing them
06/26/1996EP0718297A1 Pyrazine derivatives as muscarinic receptor agonists
06/26/1996EP0718296A1 Thermodynamically stable form of N- 4- 2-(2,4-dimethyl phenoxy)-phenyl -2-thiazolyl -1,4,5,6-tetrahydro-2-pyrimidine (DTTP)
06/26/1996EP0718295A1 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis
06/26/1996EP0718294A1 2-Amino-1,3-thiazepines and their use as inhibitors of the nitrogene oxide synthase
06/26/1996EP0718287A2 Piperazine derivatives, medicaments containing them, their use, and processes for their preparation
06/26/1996EP0718286A1 3-Alkoxybenzylpiperidine derivatives as melatonergic agents
06/26/1996EP0718285A2 Restricted 9-cis-retinoids
06/26/1996EP0718281A1 Cyclohexanediurea derivative and process for producing the same
06/26/1996EP0717998A1 Use of substance P antagonist for the treatment of pruritis, eye or eyelid pain or disesthesies
06/26/1996EP0717997A1 Use of substance P antagonist in pharmaceutical composition
06/26/1996EP0717995A2 Cell degeneration suppressing and organ toxicity reducing agent
06/26/1996EP0717994A1 New formulation for the topical treatment of psoriasis
06/26/1996EP0717993A2 Anthelmintic compositions for equidae
06/26/1996EP0717992A2 Aqueous suspension formulations for pharmaceutical applications
1 ... 6904 6905 6906 6907 6908 6909 6910 6911 6912 6913 6914 6915 6916 6917 6918 6919 6920 6921 6922 6923 6924 ... 7860